All eyes encouraged to focus on glaucoma
New national poll finds 45% of Canadians 50 and older don’t know glaucoma is a leading cause of blindness in children Canada
MONTREAL, October 14, 2021 / CNW / – Today is World Sight Day, a timely occasion to define the importance of proactive eye care and to better understand glaucoma. Glaucoma is an eye disease where increased eye pressure (intraocular pressure) can damage the optic nerve and lead to permanent vision loss.1 In a new national survey conducted by Leger Research, 45 percent of Canadians aged 50 and over are unaware that glaucoma is one of the leading causes of blindness in children. Canada.2
The survey also found that 42 percent of Canadians aged 50 and over have not seen an optometrist in the past 18 months. In addition, 24 percent of Canadians aged 50 and over experienced visual strain due to an increase in screen time in the past 18 months. Finally, according to the survey, Albertans, Ontarians, Quebeckers and Atlantic Canadians are significantly more likely to say that they have suffered from sight problems because of the extra time spent on computer screens. , smartphones, e-readers and watching TV compared to Canadians over 50 in the Prairies.
Glaucoma – Stop the sight thief
It is estimated that 400,000 Canadians are affected by glaucoma.3 A “thief of sight”, glaucoma grows slowly over time, making it difficult to detect symptoms. Canadians living with glaucoma may experience gradual narrowing of their peripheral vision. There is no cure for glaucoma and if not proactively managed it will cause damage to the optic nerve leading to irreversible loss of sight.3 However, optometrists and ophthalmologists can detect and manage glaucoma. Canadians are encouraged to learn about the effects of glaucoma and to access resources for additional support, such as the glaucoma section of the Fight Blindness Canada website (Fight Blindness.ca).
Perspective glaucoma (GiP)
In partnership with Fighting Blindness Canada, Allergan has developed the Glaucoma in Perspective (GiP) app designed to help patients understand the impact of their glaucoma and the progression of the disease. Created by teacher David crabb, the GiP app was developed with research and information on patients’ perceptions of sight loss due to glaucoma. GiP has been used throughout the UK with great success and is being adapted for Canada. The Glaucoma in Perspective (GiP) app will soon be available for free download from Apple Store and Google Play.
To acknowledge #WorldSightDay, the International Agency for the Prevention of Blindness (IAPB.org) brought together a group of leading global vision organizations and launched the #LoveYourEyes campaign, encouraging a million people around the world to have their eyes examined by October 14e.
âWorld Sight Day is an important event that comes at a particularly opportune time as the pandemic has now been with us for over 20 months. Every week I see several patients who have been lost to follow-up for over a year. due to COVID fearful of seeing their eye care team and they have now suffered cataclysmic and irreversible vision loss in one or both eyes. The most common diseases like cataracts or macular degeneration have early and noticeable symptoms for patients. Glaucoma usually first damages peripheral vision, so it may go unnoticed by patients as the disease worsens, and is therefore known as the “silent thief of sight.” tragic revelation about the consequences of delayed healthcare in many areas of medicine, and we must do everything possible to deal with its impact on the glaucoma now. ” – Dr. David B. Yan, Chief Ophthalmologist, Mount Sinai Hospital, University of Toronto – Director of the Glaucoma Department, Kensington Eye Institute.
âThere is no cure for glaucoma. That is why research is essential. However, early detection and treatment can help prevent damage to the optic nerve and save vision. Anyone can develop glaucoma, but several different factors can increase the risk of developing glaucoma. sickness. Know your risks. See your eye care professional annually to establish your baseline for eye health. You are not alone. FightingBlindness.ca has tremendous resources to help you and there are support and resources like the Perspective Glaucoma (GiP) app to help you manage the effects of glaucoma. “- Doug earle, President and CEO, Fighting Blindness Canada.
âPatients with glaucoma normally do not have symptoms of vision loss until they receive an appropriate eye exam. The goal of the GiP app is to simplify glaucoma to ensure that physicians are able to explain the disease and show an accurate visual representation of newly diagnosed patients. It is an application that makes it easy for patients to join treatment and share information about their disease with their loved ones. “- Dr. Professor David crabb, GiP application developer and professor of statistics and vision research, City University London.
“Our goal in glaucoma is to create a future where people’s vision lasts a lifetime. We understand the importance of eye care, and that’s why we continue to research new treatments to help preserve and protect vision. of our patients. We have been creating innovative products and services for healthcare providers and patients for over 70 years, and we challenge what is possible every day. We are proud to launch the new Glaucoma in Perspective (GiP ) in partnership with Fighting Blindness Canada and remain committed to supporting Canadians living with and managing eye disease. â- Tracey ramsay, Vice President and General Manager, AbbVie Canada.
About the survey
Commissioned by Allergan, an AbbVie company, the survey was conducted using Leger’s online panel between September 10 to 12, 2021 with 684 Canadians aged 50 and over. The estimated margin of error is Â± 3.75%, 19 times out of 20.
About Fighting Blindness Canada
Fighting Blindness Canada (BCF) is from Canada leading private funder of vision research. The BCF offers hope to Canadians by identifying the best and most promising research leading to treatments and cures for blinding eye disease, and by raising and managing funds to support this vital sight-saving research . In our 45-year history, FBC has invested more than $ 40 million to support vision research and education through Canada: it’s more than 200 research grants that have led to more than 600 new discoveries in fields such as stem cell research, neuroprotective therapies, technological developments, pharmaceuticals and gene therapies. The FBC is also committed to developing partnerships for funding vision research in Canada and internationally. Through these partnerships, FBC has helped unlock more than $ 10 million to advance research. All funded research and education initiatives support the goals of understanding why vision loss occurs, how it can be slowed or stopped, and how sight can be restored.
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health problems today and meet the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives in several key therapeutic areas: Immunology, Oncology, Neuroscience, Eye Care, Virology, Women’s Health and Gastroenterology, in addition to the products and services of its Allergan Aesthetics portfolio. . For more information on AbbVie, please visit us at www.abbvie.ca. To follow @abbviecanada on Twitter or find us on LinkedIn.
SOURCE Allergan, an AbbVie Company
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2021/14/c7346.html